Concurrent Hepatitis C and B Virus and Human Immunodeficiency Virus Infections Are Associated With Higher Mortality

Zahid A Butt1,2,3, Stanley Wong2, Carmine Rossi2

  • 1School of Public Health and Health Systems, University of Waterloo, Waterloo, Ontario, Canada.

Insights

Concurrent infections with Hepatitis C virus (HCV), Hepatitis B virus (HBV), and Human Immunodeficiency Virus (HIV) significantly increase mortality risk. Addressing substance use and comorbidities alongside viral treatments can reduce deaths.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Hepatitis C virus (HCV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV) are major global health concerns.
  • Limited data exist on the mortality risks associated with concurrent infections of these viruses.
  • This study investigates the impact of single and multiple viral infections on mortality in British Columbia.

Purpose of the Study:

  • To evaluate the effect of HCV, HBV, and HIV infections and coinfections on all-cause mortality.
  • To identify factors associated with increased mortality risk in individuals with these viral infections.
  • To inform public health strategies for reducing mortality related to viral coinfections.

Main Methods:

  • Utilized the BC Hepatitis Testers Cohort, including ~1.7 million individuals tested or reported for HCV, HBV, or HIV from 1990-2015.
  • Followed individuals with monoinfection, coinfections, or triple infections from their negative status to death or end of 2016.
  • Employed extended Cox proportional hazards regression to determine mortality risk factors and hazard ratios (HRs).

Main Results:

  • Out of 658,704 individuals, 33,804 (5.13%) deaths were recorded.
  • HCV/HBV/HIV triple infection showed the highest mortality risk (HR, 8.9), followed by HCV/HIV (HR, 4.8), HBV/HIV (HR, 4.1), and HCV/HBV (HR, 3.9).
  • Monoinfections also increased mortality risk (HCV: HR 2.6, HBV: HR 2.2, HIV: HR 1.6), with injection drug use, alcohol use, material deprivation, and comorbidities being significant factors.

Conclusions:

  • Concurrent multiple viral infections are strongly linked to elevated mortality.
  • Substance use, comorbidities, and socioeconomic factors independently contribute to mortality risk.
  • Integrated preventive strategies, including harm reduction and coinfection treatment, are crucial for reducing mortality.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.8K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
679
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
580
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.8K
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.6K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.6K